In this context, it is remarkable that drug costs in the intervention groups decreased significantly, although past queries have shown the opposite phenomenon in the aftermath of educational activities. Obviously, there is no backlog demand in the investigated population, and better compliance has given leeway to dose reductions, at least in the intervention groups.
Another hint at a relatively good asthma control in the pre-run to the current survey is the small number of hospitalizations recorded for study participants. In contrast to population-based surveys in which hospitalization costs make up between 53% and 72% of all direct costs, the initial range of 3% (IEP group) to 7% (SPMP group) in our study documents the potential selection bias of well-controlled asthmatics when compared to the average.
Despite the above-average quality level of care at baseline, study participants benefited from patient education. In the second half of the observation period, only one patient (2%) in the IEP group and four patients (5%) in SPMP group had an emergency event. This approximates the Global initiative for Asthma recommendations that demand the absence of any asthma-related emergency. canadian family pharmacy
Health-care utilization data and work absence of caregivers were recorded retrospectively at each of the study visits. This might raise the presumption that these data are subject to a recall bias. However, doctors performed out major parts of this documentation (eg, number of outpatient visits) based on (electronic) patient records. If necessary, patients and caregivers provided additional information on number and devolution of emergencies (emergency department visits and ambulance transports). These data seem to be easily recollected by patients and caregivers due to their drastic consequences. Furthermore, a precedent study has proven a high consistency between the data provided by patients and that provided by the health insurance agencies. Therefore we consider the potential overestimation or underestimation of health-care resource use as minimal.
We find our results encouraging enough to anticipate further implementation activities in cooperation with local and regional paymasters. In either case, regional campaigns boosting the use of the IEP will have to be accompanied by continuous economic evaluations in order to verify its long-term effects on medical and economic outcomes and to quantify the effects on the benefit-cost ratio when both patient and provider groups will be expanded.